Cinacalcet Hydrochloride Tablets
CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable daily intake (ADI) limits.
2,357 recalls · Class II, newest first
CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable daily intake (ADI) limits.
CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable daily intake (ADI) limits.
Failed impurities/degradation specifications: out of specification results for Ganirelix acetate acrylic acid adduct impurity.
Microbial contamination of a non-sterile product - microorganism found to be pseudomonas lactis
Defective container - seal not adhering to bottles
Defective container: cracked/broken cartridges
Defective container: cracked/broken cartridges
Defective container: cracked/broken cartridges
Defective container: cracked/broken cartridges
Defective container: cracked/broken cartridges
Defective container: cracked/broken cartridges
Defective container: cracked/broken cartridges
cGMP deviations
cGMP deviations
cGMP deviations
cGMP deviations
cGMP deviations
cGMP deviations
cGMP deviations
cGMP deviations
cGMP deviations
cGMP deviations
cGMP deviations
cGMP deviations
cGMP deviations